Femarelle® and bone mineral density ‐ Scientific substantiation of a health claim related to “Femarelle®” and “induces bone formation and increases bone mineral density reducing the risk for osteoporosis and other bone disorders” pursuant to Article 14 of the Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
Main Author: | European Food Safety Authority (EFSA) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-08-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2008.785 |
Similar Items
-
Calcium and bone growth ‐ Scientific substantiation of a health claim related to calcium and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-10-01) -
Animal protein and bone growth ‐ Scientific substantiation of a health claim related to animal protein and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-11-01) -
Vitamin D and bone growth ‐ Scientific substantiation of a health claim related to vitamin D and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-10-01) -
Calcium + Vitamin D3 chewing tablets and bone loss ‐ Scientific substantiation of a health claim related to Calcium plus Vitamin D3 chewing tablets and reduction of the risk of osteoporotic fractures by reducing bone loss pursuant to Article 14 of Regulation (EC) No 1924/2006
by: European Food Safety Authority (EFSA)
Published: (2009-08-01) -
Bone mineral density: review
by: ICL Almeida Paz, et al.
Published: (2006-06-01)